Skip to main content
Log in

SIAMS-ONIG Consensus on hormonal treatment in gender identity disorders

  • Consensus
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Osservatorio Nazionale sull’Identità di Genere — ONIG. Italian Standards of Care for Sex Reassignment in Gender Identity Disorder. http://www.onig.it

  2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSMIVTR) (4th ed, Text Revision). Washington DC: American Psychiatric Association, 2000.

    Google Scholar 

  3. Zitzmann M. The role of the CAG repeat androgen receptor polymorphism in andrology. Front Horm Res 2009, 37: 52–61.

    Article  CAS  PubMed  Google Scholar 

  4. Zitzmann M, Depenbusch M, Gromoll J, Nieschlag E. X-chromosome inactivation patterns and androgen receptor functionality influence phenotype and social characteristics as well as pharmacogenetics of testosterone therapy in Klinefelter patients. J Clin Endocrinol Metab 2004, 89: 6208–17.

    Article  CAS  PubMed  Google Scholar 

  5. Dahl M, Feldman JL, Goldberg JM, Jaberi A. Physical aspects of trans-gender endocrine therapy. Int J Transgenderism 2006, 9: 111–34.

    Article  Google Scholar 

  6. Asscheman H, Gooren LJ, Assies J, Smits JP, de Slegte R. Prolactin levels and pituitary enlargement in hormone-treated male-to-female transsexuals. Clin Endocrinol (Oxf) 1988, 28: 583–8.

    Article  CAS  Google Scholar 

  7. Istituto Superiore di Sanità. Conferenza Nazionale di Consenso. Salute della donna. Prevenzione delle complicanze trombotiche associate all’uso di estro-progestinici in età riproduttiva. Roma, 18–19 settembre 2008.

  8. Benjamin H. Il fenomeno transessuale. Rome: Astrolabio Ubaldini Editore, 1966.

    Google Scholar 

  9. Futterweit W. Endocrine therapy of transsexualism and potential complications of long-term treatment. Arch Sex Behav 1998, 27: 209–26.

    Article  CAS  PubMed  Google Scholar 

  10. Godano A. Terapia medica nel transessualismo. G Ital Androl 1995, 2: 160–4.

    Google Scholar 

  11. Levy A, Crown A, Reid R. Endocrine intervention for transsexuals. Clin Endocrinol (Oxf) 2003, 59: 409–18.

    Article  CAS  Google Scholar 

  12. Jannini EA, Lenzi A, Wagner G. Behavioural therapy and counselling. In: Schill WB, Comhaire FH, Hargreave TB eds. Andrology for the Clinician. Berlin: Springer. 2006. 598–607.

    Chapter  Google Scholar 

  13. Gooren LJ, Delemarre Van de Waal A. Hormone Treatment of Adult and Juvenile Transsexual Patients. In: Ettner R, Monstrey S, Eyler E eds. Principles of transgender medicine and surgery. The New York: Haworth Press, 2007.

    Google Scholar 

  14. Gooren LJ, Giltay EJ, Bunck MC. Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience. J Clin Endocrinol Metab 2008, 93: 19–25.

    Article  CAS  PubMed  Google Scholar 

  15. Manieri C, Godano A, Lanfranco F, Di Bisceglie C, Ghigo E, Maggi M, Lenzi A, Jannini EA. Hormone treatment in gender dysphoria. Sexologies 2008, 17: 265–70.

    Article  Google Scholar 

  16. Hembree WC, Cohen-Kettenis P, Delemarre-van de Waal HA, et al; Endocrine Society. Endocrine treatment of transsexuals persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2009, 94: 3132–54.

    Article  CAS  PubMed  Google Scholar 

  17. Cohen-Kettenis PT, Delemarre-van de Waal HA, Gooren LJ. The treatment of adolescent transsexuals: changing insight. J Sex Med 2008, 5: 1892–7.

    Article  PubMed  Google Scholar 

  18. Dittrich R, Binder H, Cupisti S, Hoffmann I, Beckmann MW, Mueller A. Endocrine treatment of male-to-female transsexuals using gonadotropin-releasing hormone agonist. Exp Clin Endocrinol Diab 2005, 113: 586–92.

    Article  CAS  Google Scholar 

  19. Mueller A, Kiesewetter F, Binder H, Beckmann MW, Dittrich R. Long-term administration of testosterone undecanoate every 3 months for testosterone supplementation in female-to-male transsexuals. J Clin Endocrinol Metab 2007, 92: 3470–5.

    Article  CAS  PubMed  Google Scholar 

  20. Jacobeit JW, Gooren LJ, Schulte HM. Long-acting intramuscular testosterone undecanoate for treatment of female-to-male trans-gender individuals. J Sex Med 2007, 4: 1479–84.

    Article  CAS  PubMed  Google Scholar 

  21. Moore E, Wisniewski A, Dobs A. Endocrine treatment of transsexuals people: a review of treatment regimens, outcomes and adverse effects. J Clin Endocrinol Metab 2003, 88: 3467–73.

    Article  CAS  PubMed  Google Scholar 

  22. Mueller A, Gooren L. Hormone-related tumors in transsexuals receiving treatment with cross-sex hormones. Eur J Endocrinol 2008, 159: 197–202.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Manieri MD.

Additional information

SIAMS: Società Italiana di Andrologia e Medicina della Sessualità (Italian Society of Andrology and Sexual Medicine); ONIG: Osservatorio Nazionale sull’Identità di Genere (National Observatory of Gender Identity).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Godano, A., Maggi, M., Jannini, E. et al. SIAMS-ONIG Consensus on hormonal treatment in gender identity disorders. J Endocrinol Invest 32, 857–864 (2009). https://doi.org/10.1007/BF03345758

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03345758

Keywords

Navigation